IBDEI16G ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,19105,0)
;;=L40.9^^64^849^17
;;^UTILITY(U,$J,358.3,19105,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19105,1,3,0)
;;=3^Psoriasis,Unspec
;;^UTILITY(U,$J,358.3,19105,1,4,0)
;;=4^L40.9
;;^UTILITY(U,$J,358.3,19105,2)
;;=^5009171
;;^UTILITY(U,$J,358.3,19106,0)
;;=L40.3^^64^849^19
;;^UTILITY(U,$J,358.3,19106,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19106,1,3,0)
;;=3^Pustulosis Palmaris et Plantaris
;;^UTILITY(U,$J,358.3,19106,1,4,0)
;;=4^L40.3
;;^UTILITY(U,$J,358.3,19106,2)
;;=^5009163
;;^UTILITY(U,$J,358.3,19107,0)
;;=R21.^^64^849^20
;;^UTILITY(U,$J,358.3,19107,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19107,1,3,0)
;;=3^Rash/Oth Nonspecific Skin Eruption
;;^UTILITY(U,$J,358.3,19107,1,4,0)
;;=4^R21.
;;^UTILITY(U,$J,358.3,19107,2)
;;=^5019283
;;^UTILITY(U,$J,358.3,19108,0)
;;=L25.9^^64^849^6
;;^UTILITY(U,$J,358.3,19108,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19108,1,3,0)
;;=3^Contact Dermatitis,Unspec
;;^UTILITY(U,$J,358.3,19108,1,4,0)
;;=4^L25.9
;;^UTILITY(U,$J,358.3,19108,2)
;;=^5133647
;;^UTILITY(U,$J,358.3,19109,0)
;;=M34.89^^64^850^31
;;^UTILITY(U,$J,358.3,19109,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19109,1,3,0)
;;=3^Systemic Sclerosis NEC
;;^UTILITY(U,$J,358.3,19109,1,4,0)
;;=4^M34.89
;;^UTILITY(U,$J,358.3,19109,2)
;;=^5011784
;;^UTILITY(U,$J,358.3,19110,0)
;;=M34.0^^64^850^25
;;^UTILITY(U,$J,358.3,19110,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19110,1,3,0)
;;=3^Progressive Systemic Sclerosis
;;^UTILITY(U,$J,358.3,19110,1,4,0)
;;=4^M34.0
;;^UTILITY(U,$J,358.3,19110,2)
;;=^5011778
;;^UTILITY(U,$J,358.3,19111,0)
;;=F03.90^^64^850^15
;;^UTILITY(U,$J,358.3,19111,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19111,1,3,0)
;;=3^Dementia w/o Behavioral Disturbance,Unspec
;;^UTILITY(U,$J,358.3,19111,1,4,0)
;;=4^F03.90
;;^UTILITY(U,$J,358.3,19111,2)
;;=^5003050
;;^UTILITY(U,$J,358.3,19112,0)
;;=F06.8^^64^850^22
;;^UTILITY(U,$J,358.3,19112,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19112,1,3,0)
;;=3^Mental Disorders d/t Physiological Condition
;;^UTILITY(U,$J,358.3,19112,1,4,0)
;;=4^F06.8
;;^UTILITY(U,$J,358.3,19112,2)
;;=^5003062
;;^UTILITY(U,$J,358.3,19113,0)
;;=F06.1^^64^850^1
;;^UTILITY(U,$J,358.3,19113,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19113,1,3,0)
;;=3^Catatonic Disorder d/t Physiological Condition
;;^UTILITY(U,$J,358.3,19113,1,4,0)
;;=4^F06.1
;;^UTILITY(U,$J,358.3,19113,2)
;;=^5003054
;;^UTILITY(U,$J,358.3,19114,0)
;;=G35.^^64^850^23
;;^UTILITY(U,$J,358.3,19114,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19114,1,3,0)
;;=3^Multiple Sclerosis
;;^UTILITY(U,$J,358.3,19114,1,4,0)
;;=4^G35.
;;^UTILITY(U,$J,358.3,19114,2)
;;=^79761
;;^UTILITY(U,$J,358.3,19115,0)
;;=G60.9^^64^850^20
;;^UTILITY(U,$J,358.3,19115,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19115,1,3,0)
;;=3^Hereditary/Idiopathic Neuropathy,Unspec
;;^UTILITY(U,$J,358.3,19115,1,4,0)
;;=4^G60.9
;;^UTILITY(U,$J,358.3,19115,2)
;;=^5004071
;;^UTILITY(U,$J,358.3,19116,0)
;;=G62.9^^64^850^24
;;^UTILITY(U,$J,358.3,19116,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19116,1,3,0)
;;=3^Polyneuropathy,Unspec
;;^UTILITY(U,$J,358.3,19116,1,4,0)
;;=4^G62.9
;;^UTILITY(U,$J,358.3,19116,2)
;;=^5004079
;;^UTILITY(U,$J,358.3,19117,0)
;;=I63.9^^64^850^14
;;^UTILITY(U,$J,358.3,19117,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19117,1,3,0)
;;=3^Cerebral Infarction,Unspec
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI16G 3813 printed Apr 09, 2024@20:47:05 Page 2
IBDEI16G ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,19105,0)
+2 ;;=L40.9^^64^849^17
+3 ;;^UTILITY(U,$J,358.3,19105,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,19105,1,3,0)
+6 ;;=3^Psoriasis,Unspec
+7 ;;^UTILITY(U,$J,358.3,19105,1,4,0)
+8 ;;=4^L40.9
+9 ;;^UTILITY(U,$J,358.3,19105,2)
+10 ;;=^5009171
+11 ;;^UTILITY(U,$J,358.3,19106,0)
+12 ;;=L40.3^^64^849^19
+13 ;;^UTILITY(U,$J,358.3,19106,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,19106,1,3,0)
+16 ;;=3^Pustulosis Palmaris et Plantaris
+17 ;;^UTILITY(U,$J,358.3,19106,1,4,0)
+18 ;;=4^L40.3
+19 ;;^UTILITY(U,$J,358.3,19106,2)
+20 ;;=^5009163
+21 ;;^UTILITY(U,$J,358.3,19107,0)
+22 ;;=R21.^^64^849^20
+23 ;;^UTILITY(U,$J,358.3,19107,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,19107,1,3,0)
+26 ;;=3^Rash/Oth Nonspecific Skin Eruption
+27 ;;^UTILITY(U,$J,358.3,19107,1,4,0)
+28 ;;=4^R21.
+29 ;;^UTILITY(U,$J,358.3,19107,2)
+30 ;;=^5019283
+31 ;;^UTILITY(U,$J,358.3,19108,0)
+32 ;;=L25.9^^64^849^6
+33 ;;^UTILITY(U,$J,358.3,19108,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,19108,1,3,0)
+36 ;;=3^Contact Dermatitis,Unspec
+37 ;;^UTILITY(U,$J,358.3,19108,1,4,0)
+38 ;;=4^L25.9
+39 ;;^UTILITY(U,$J,358.3,19108,2)
+40 ;;=^5133647
+41 ;;^UTILITY(U,$J,358.3,19109,0)
+42 ;;=M34.89^^64^850^31
+43 ;;^UTILITY(U,$J,358.3,19109,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,19109,1,3,0)
+46 ;;=3^Systemic Sclerosis NEC
+47 ;;^UTILITY(U,$J,358.3,19109,1,4,0)
+48 ;;=4^M34.89
+49 ;;^UTILITY(U,$J,358.3,19109,2)
+50 ;;=^5011784
+51 ;;^UTILITY(U,$J,358.3,19110,0)
+52 ;;=M34.0^^64^850^25
+53 ;;^UTILITY(U,$J,358.3,19110,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,19110,1,3,0)
+56 ;;=3^Progressive Systemic Sclerosis
+57 ;;^UTILITY(U,$J,358.3,19110,1,4,0)
+58 ;;=4^M34.0
+59 ;;^UTILITY(U,$J,358.3,19110,2)
+60 ;;=^5011778
+61 ;;^UTILITY(U,$J,358.3,19111,0)
+62 ;;=F03.90^^64^850^15
+63 ;;^UTILITY(U,$J,358.3,19111,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,19111,1,3,0)
+66 ;;=3^Dementia w/o Behavioral Disturbance,Unspec
+67 ;;^UTILITY(U,$J,358.3,19111,1,4,0)
+68 ;;=4^F03.90
+69 ;;^UTILITY(U,$J,358.3,19111,2)
+70 ;;=^5003050
+71 ;;^UTILITY(U,$J,358.3,19112,0)
+72 ;;=F06.8^^64^850^22
+73 ;;^UTILITY(U,$J,358.3,19112,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,19112,1,3,0)
+76 ;;=3^Mental Disorders d/t Physiological Condition
+77 ;;^UTILITY(U,$J,358.3,19112,1,4,0)
+78 ;;=4^F06.8
+79 ;;^UTILITY(U,$J,358.3,19112,2)
+80 ;;=^5003062
+81 ;;^UTILITY(U,$J,358.3,19113,0)
+82 ;;=F06.1^^64^850^1
+83 ;;^UTILITY(U,$J,358.3,19113,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,19113,1,3,0)
+86 ;;=3^Catatonic Disorder d/t Physiological Condition
+87 ;;^UTILITY(U,$J,358.3,19113,1,4,0)
+88 ;;=4^F06.1
+89 ;;^UTILITY(U,$J,358.3,19113,2)
+90 ;;=^5003054
+91 ;;^UTILITY(U,$J,358.3,19114,0)
+92 ;;=G35.^^64^850^23
+93 ;;^UTILITY(U,$J,358.3,19114,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,19114,1,3,0)
+96 ;;=3^Multiple Sclerosis
+97 ;;^UTILITY(U,$J,358.3,19114,1,4,0)
+98 ;;=4^G35.
+99 ;;^UTILITY(U,$J,358.3,19114,2)
+100 ;;=^79761
+101 ;;^UTILITY(U,$J,358.3,19115,0)
+102 ;;=G60.9^^64^850^20
+103 ;;^UTILITY(U,$J,358.3,19115,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,19115,1,3,0)
+106 ;;=3^Hereditary/Idiopathic Neuropathy,Unspec
+107 ;;^UTILITY(U,$J,358.3,19115,1,4,0)
+108 ;;=4^G60.9
+109 ;;^UTILITY(U,$J,358.3,19115,2)
+110 ;;=^5004071
+111 ;;^UTILITY(U,$J,358.3,19116,0)
+112 ;;=G62.9^^64^850^24
+113 ;;^UTILITY(U,$J,358.3,19116,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,19116,1,3,0)
+116 ;;=3^Polyneuropathy,Unspec
+117 ;;^UTILITY(U,$J,358.3,19116,1,4,0)
+118 ;;=4^G62.9
+119 ;;^UTILITY(U,$J,358.3,19116,2)
+120 ;;=^5004079
+121 ;;^UTILITY(U,$J,358.3,19117,0)
+122 ;;=I63.9^^64^850^14
+123 ;;^UTILITY(U,$J,358.3,19117,1,0)
+124 ;;=^358.31IA^4^2
+125 ;;^UTILITY(U,$J,358.3,19117,1,3,0)
+126 ;;=3^Cerebral Infarction,Unspec
